Mark A. Socinski, MD, executive director of the AdventHealth Cancer Institute, shares his insight on liquid- and tissue-based biopsies and their clinical utility in non–small cell lung cancer (NSCLC).

A pilot study comparing the effects of a liquid biopsy with tissue-based test showed that liquid biopsy turn-around time for results was approximately 10 days faster than the tissue biopsy, according ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient concerns about technology understanding and insurance coverage, as well as ...

A single-center experience with CELLSEARCH system circulating tumor cell test on patients with metastatic breast cancer. BIM deletion polymorphism and the clinical outcome of patients with advanced ...

Sampling diseased tissue, which can contain many different types of cells, calls for precise biomedical tools. Current methods for manipulating single cells, like laser microdissection, require ...

Please provide your email address to receive an email when new articles are posted on . Biopsy details, including the operator’s training and any intra-articular steroids used prior to the procedure, ...

In lifesaving situations, expedient and accurate diagnostic tools are critical to aid pathologists in examining biopsied tissue samples looking for signs of diseases. Engineers found a new path to ...

FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug ...

Denver--October 2, 2020--A pilot study comparing the effects of a liquid biopsy with tissue-based test showed that liquid biopsy turn-around time for results was approximately 10 days faster than the ...